639 related articles for article (PubMed ID: 25615431)
1. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
2. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
3. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
5. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
[TBL] [Abstract][Full Text] [Related]
6. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
7. Toxicity testing in the 21st century beyond environmental chemicals.
Rovida C; Asakura S; Daneshian M; Hofman-Huether H; Leist M; Meunier L; Reif D; Rossi A; Schmutz M; Valentin JP; Zurlo J; Hartung T
ALTEX; 2015; 32(3):171-81. PubMed ID: 26168280
[TBL] [Abstract][Full Text] [Related]
8. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.
van Vliet E
ALTEX; 2011; 28(1):17-44. PubMed ID: 21311848
[TBL] [Abstract][Full Text] [Related]
9. In vitro approaches for detection of chemical sensitization.
Roggen EL
Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):32-40. PubMed ID: 24472442
[TBL] [Abstract][Full Text] [Related]
10. Application of omics data in regulatory toxicology: report of an international BfR expert workshop.
Marx-Stoelting P; Braeuning A; Buhrke T; Lampen A; Niemann L; Oelgeschlaeger M; Rieke S; Schmidt F; Heise T; Pfeil R; Solecki R
Arch Toxicol; 2015 Nov; 89(11):2177-84. PubMed ID: 26486796
[TBL] [Abstract][Full Text] [Related]
11. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
12. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.
Patlewicz G; Simon TW; Rowlands JC; Budinsky RA; Becker RA
Regul Toxicol Pharmacol; 2015 Apr; 71(3):463-77. PubMed ID: 25707856
[TBL] [Abstract][Full Text] [Related]
13. Toxicity testing in the 21st century: how will it affect risk assessment?
Rhomberg LR
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
[TBL] [Abstract][Full Text] [Related]
14. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
[TBL] [Abstract][Full Text] [Related]
15. Adverse outcome pathway-based screening strategies for an animal-free safety assessment of chemicals.
Landesmann B; Mennecozzi M; Berggren E; Whelan M
Altern Lab Anim; 2013 Dec; 41(6):461-71. PubMed ID: 24512230
[TBL] [Abstract][Full Text] [Related]
16. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
17. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
Kroeger M
Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
[TBL] [Abstract][Full Text] [Related]
18. Adverse outcome pathway development from protein alkylation to liver fibrosis.
Horvat T; Landesmann B; Lostia A; Vinken M; Munn S; Whelan M
Arch Toxicol; 2017 Apr; 91(4):1523-1543. PubMed ID: 27542122
[TBL] [Abstract][Full Text] [Related]
19. The future of toxicity testing.
Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
[TBL] [Abstract][Full Text] [Related]
20. Toxicity testing in the 21st century: bringing the vision to life.
Andersen ME; Krewski D
Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
